FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1540885629> ?p ?o ?g. }

• W1540885629 endingPage "303" @default.
• W1540885629 startingPage "293" @default.
• W1540885629 abstract "The calcium-activated potassium channel KCa3.1 is expressed in the vascular endothelium where its activation causes endothelial hyperpolarization and initiates endothelium-derived hyperpolarization (EDH)-dependent dilatation. Here, we investigated whether pharmacological activation of KCa3.1 dilates skeletal muscle arterioles and whether myoendothelial gap junctions formed by connexin40 (Cx40) are required for EDH-type dilatations and pressure depressor responses in vivo.We performed intravital microscopy in the cremaster muscle microcirculation and blood pressure telemetry in Cx40-deficient mice.In wild-type mice, the KCa3.1-activator SKA-31 induced pronounced concentration-dependent arteriolar EDH-type dilatations, amounting to ∼40% of maximal dilatation, and enhanced the effects of ACh. These responses were absent in mice devoid of KCa3.1 channels. In contrast, SKA-31-induced dilatations were not attenuated in mice with endothelial cells deficient in Cx40 (Cx40(fl/fl):Tie2-Cre). In isolated endothelial cell clusters, SKA-31 induced hyperpolarizations of similar magnitudes (by ∼38 mV) in Cx40(fl/fl):Tie2-Cre, ubiquitous Cx40-deficient mice (Cx40(-/-)) and controls (Cx40(fl/fl)), which were reversed by the specific KCa3.1-blocker TRAM-34. In normotensive wild-type and Cx40(fl/fl):Tie2-Cre as well as in hypertensive Cx40(-/-) animals, i.p. injections of SKA-31 (30 and 100 mg·kg(-1)) decreased arterial pressure by ∼32 mmHg in all genotypes. The depressor response to 100 mg·kg(-1) SKA-31 was associated with a decrease in heart rate.We conclude that endothelial hyperpolarization evoked by pharmacological activation of KCa3.1 channels induces EDH-type arteriolar dilatations that are independent of endothelial Cx40 and Cx40-containing myoendothelial gap junctions. As SKA-31 reduced blood pressure in hypertensive Cx40-deficient mice, KCa3.1 activators may be useful drugs for severe treatment-resistant hypertension." @default.
• W1540885629 created "2016-06-24" @default.
• W1540885629 creator A5026660883 @default.
• W1540885629 creator A5032426141 @default.
• W1540885629 creator A5043905627 @default.
• W1540885629 creator A5061674579 @default.
• W1540885629 creator A5064743256 @default.
• W1540885629 date "2013-08-27" @default.
• W1540885629 modified "2023-10-12" @default.
• W1540885629 title "Activation of K_Ca3.1 by SKA-31 induces arteriolar dilatation and lowers blood pressure in normo- and hypertensive connexin40-deficient mice" @default.
• W1540885629 cites W1489379070 @default.
• W1540885629 cites W1521761936 @default.
• W1540885629 cites W1561099903 @default.
• W1540885629 cites W1593555249 @default.
• W1540885629 cites W1598625403 @default.
• W1540885629 cites W1684778245 @default.
• W1540885629 cites W1916800927 @default.
• W1540885629 cites W1967166579 @default.
• W1540885629 cites W1982580263 @default.
• W1540885629 cites W1985475179 @default.
• W1540885629 cites W1986916729 @default.
• W1540885629 cites W1991353211 @default.
• W1540885629 cites W1992874010 @default.
• W1540885629 cites W2016228454 @default.
• W1540885629 cites W2027841061 @default.
• W1540885629 cites W2029068605 @default.
• W1540885629 cites W2032019404 @default.
• W1540885629 cites W2032701963 @default.
• W1540885629 cites W2039867038 @default.
• W1540885629 cites W2040437516 @default.
• W1540885629 cites W2054455749 @default.
• W1540885629 cites W2061593357 @default.
• W1540885629 cites W2064075744 @default.
• W1540885629 cites W2064489455 @default.
• W1540885629 cites W2065417822 @default.
• W1540885629 cites W2073786590 @default.
• W1540885629 cites W2076253183 @default.
• W1540885629 cites W2076989031 @default.
• W1540885629 cites W2101520511 @default.
• W1540885629 cites W2112433389 @default.
• W1540885629 cites W2118584840 @default.
• W1540885629 cites W2120411875 @default.
• W1540885629 cites W2121048488 @default.
• W1540885629 cites W2121827002 @default.
• W1540885629 cites W2125546821 @default.
• W1540885629 cites W2126556312 @default.
• W1540885629 cites W2137985469 @default.
• W1540885629 cites W2138675675 @default.
• W1540885629 cites W2139752050 @default.
• W1540885629 cites W2148619921 @default.
• W1540885629 cites W2150302448 @default.
• W1540885629 cites W2161387630 @default.
• W1540885629 cites W2162036293 @default.
• W1540885629 cites W2162049786 @default.
• W1540885629 cites W2168126615 @default.
• W1540885629 cites W2170573153 @default.
• W1540885629 cites W2951870536 @default.
• W1540885629 doi "https://doi.org/10.1111/bph.12267" @default.
• W1540885629 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3834754" @default.
• W1540885629 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23734697" @default.
• W1540885629 hasPublicationYear "2013" @default.
• W1540885629 type Work @default.
• W1540885629 sameAs 1540885629 @default.
• W1540885629 citedByCount "42" @default.
• W1540885629 countsByYear W15408856292013 @default.
• W1540885629 countsByYear W15408856292014 @default.
• W1540885629 countsByYear W15408856292015 @default.
• W1540885629 countsByYear W15408856292016 @default.
• W1540885629 countsByYear W15408856292017 @default.
• W1540885629 countsByYear W15408856292018 @default.
• W1540885629 countsByYear W15408856292019 @default.
• W1540885629 countsByYear W15408856292020 @default.
• W1540885629 countsByYear W15408856292021 @default.
• W1540885629 countsByYear W15408856292022 @default.
• W1540885629 countsByYear W15408856292023 @default.
• W1540885629 crossrefType "journal-article" @default.
• W1540885629 hasAuthorship W1540885629A5026660883 @default.
• W1540885629 hasAuthorship W1540885629A5032426141 @default.
• W1540885629 hasAuthorship W1540885629A5043905627 @default.
• W1540885629 hasAuthorship W1540885629A5061674579 @default.
• W1540885629 hasAuthorship W1540885629A5064743256 @default.
• W1540885629 hasBestOaLocation W15408856292 @default.
• W1540885629 hasConcept C126322002 @default.
• W1540885629 hasConcept C12722491 @default.
• W1540885629 hasConcept C131453863 @default.
• W1540885629 hasConcept C134018914 @default.
• W1540885629 hasConcept C178790620 @default.
• W1540885629 hasConcept C185592680 @default.
• W1540885629 hasConcept C2776354463 @default.
• W1540885629 hasConcept C2776992346 @default.
• W1540885629 hasConcept C2779482390 @default.
• W1540885629 hasConcept C2780419564 @default.
• W1540885629 hasConcept C2780733407 @default.
• W1540885629 hasConcept C2859252 @default.
• W1540885629 hasConcept C66974803 @default.
• W1540885629 hasConcept C71924100 @default.
• W1540885629 hasConcept C83743174 @default.
• W1540885629 hasConcept C84393581 @default.

• next